Phosphatase and tensin homolog deficiency and resistance to trastuzumab and chemotherapy
- PMID: 23650407
- DOI: 10.1200/JCO.2012.48.5243
Phosphatase and tensin homolog deficiency and resistance to trastuzumab and chemotherapy
Comment on
-
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.J Clin Oncol. 2013 Jun 10;31(17):2115-22. doi: 10.1200/JCO.2012.42.2642. Epub 2013 May 6. J Clin Oncol. 2013. PMID: 23650412 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
